A detailed history of West Branch Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, West Branch Capital LLC holds 200 shares of NVS stock, worth $20,762. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$20,762
Previous $21,000 9.52%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $4,005 - $4,531
50 Added 33.33%
200 $18,000
Q4 2021

Jan 24, 2022

BUY
$79.7 - $88.13 $7,173 - $7,931
90 Added 150.0%
150 $13,000
Q2 2021

Aug 17, 2021

BUY
$85.24 - $94.15 $5,114 - $5,649
60 New
60 $5,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track West Branch Capital LLC Portfolio

Follow West Branch Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.